Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hollander NH"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Iveson TJ; University of Southampton, Southampton, United Kingdom., Sobrero AF; Ospedale Policlinico San Martino IRCCS, Genova, Italy., Yoshino T; National Cancer Center Hospital East, Kashiwa, Japan., Souglakos I; Department of Medical Oncology, University Hospital of Heraklion, Iraklio, Greece., Ou FS; Mayo Clinic, Rochester, MN., Meyers JP; Mayo Clinic, Rochester, MN., Shi Q; Mayo Clinic, Rochester, MN., Grothey A; West Cancer Center and Research Institute, Germantown, TN., Saunders MP; Christie Hospital, Manchester, United Kingdom., Labianca R; Cancer Center, Ospedale Papa Giovanni XXIII Bergamo, Bergamo, Italy., Yamanaka T; Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan., Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece., Hollander NH; IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy., Galli F; IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy., Yamazaki K; Shizuoka Cancer Center, Shizuoka, Japan., Georgoulias V; Hellenic Oncology Research Group, Athens, Greece., Kerr R; University of Oxford, Oxford, United Kingdom., Oki E; Kyushu University, Fukuoka, Japan., Lonardi S; Veneto Institute of Oncology IRCCS, Padua, Italy., Harkin A; University of Glasgow, Institute of Cancer Sciences, Scotland, United Kingdom., Rosati G; San Carlo Hospital, Potenza, Italy., Paul J; University of Glasgow, Institute of Cancer Sciences, Scotland, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Feb 20; Vol. 39 (6), pp. 631-641. Date of Electronic Publication: 2021 Jan 13.
Autor:
Iveson T; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Robles-Zurita J; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Saunders MP; The Christie Hospital NHS Foundation Trust, Manchester, UK., Briggs AH; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group, Camperdown, NSW, Australia., Glimelius B; University of Uppsala, Uppsala, Sweden., Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Pearson S; Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, UK., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow, UK., Medley L; Royal United Hospital, Bath, UK., Wilson C; Addenbrooke's Hospital, Cambridge, UK., Ellis R; Royal Cornwall Hospitals NHS Trust, Cornwall, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Dhadda AS; Castle Hill Hospital, Hull, UK., Harrison M; Mount Vernon Cancer Centre, Northwood, UK., Falk S; Bristol Cancer Institute, Bristol, UK., Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Bridgewater J; Department of Oncology, University College London, London, UK., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, UK., Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK., Cunningham D; Royal Marsden NHS Foundation Trust, London, UK., Hickish T; Poole Hospital NHS Foundation Trust, Poole, UK., Weaver A; Department of Oncology, Oxford University Hospitals Foundation Trust, Oxford, UK., Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK., Wasan H; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Paul J; The Christie Hospital NHS Foundation Trust, Manchester, UK.
Publikováno v:
Health technology assessment (Winchester, England) [Health Technol Assess] 2019 Dec; Vol. 23 (64), pp. 1-88.
Autor:
Robles-Zurita J; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK. JoseAntonio.Robles-Zurita@glasgow.ac.uk., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Briggs AH; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Iveson T; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Saunders MP; The Christie Hospital, Manchester, UK., Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hollander NH; Zealand University Hospital, Department of Oncology and Palliative Care, Rǻdmandsengen 5, DK 4700, Naestved, Denmark., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Segelov E; Australasian Gastro-Intestinal Trials Group (AGITG) and Monash University and Monash Health, Melbourne, Australia., Glimelius B; University of Uppsala, Uppsala, Sweden., Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Pearson S; Department of Oncology, OCTO, University of Oxford, Oxford, UK., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow, UK., Medley L; Royal United Hospital, Bath, UK., Wilson C; Addenbrookes Hospital, Cambridge, UK., Ellis R; Royal Cornwall Hospitals NHS Trust, Cornwall, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Dhadda AS; Castle Hill Hospital, Hull, UK., Hughes R; Mount Vernon Cancer Centre, Northwood, UK., Falk S; Bristol Cancer Institute, Bristol, UK., Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Olesen RK; Zealand University Hospital, Department of Oncology and Palliative Care, Rǻdmandsengen 5, DK 4700, Naestved, Denmark., Propper D; Barts Cancer Institute, Queen Mary, University of London, London, UK., Bridgewater J; University College London, London, UK., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK., Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK., Cunningham D; Royal Marsden (funded by NIHR BRC at the Royal Marsden), London, UK., Hickish T; Poole Hospital/Bournemouth University, Bournemouth, UK., Weaver A; Churchill Hospital, Oxford University Hospitals Foundation Trust, Oxford, UK., Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK., Wasan HS; Hammersmith Hospital, Imperial College London, London, UK., Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2018 Nov; Vol. 119 (11), pp. 1332-1338. Date of Electronic Publication: 2018 Nov 13.
Autor:
Iveson TJ; Southampton University Hospital NHS Foundation Trust, Southampton, UK. Electronic address: tim.iveson@uhs.nhs.uk., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Saunders MP; The Christie Hospital, Manchester, UK., Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group, Melbourne, VIC, Australia., Glimelius B; IGP, University of Uppsala, Uppsala, Sweden., Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Scudder C; OCTO, University of Oxford, Department of Oncology, Oxford, UK., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Briggs A; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK; Center for Health and Policy Outcomes, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow UK., Medley L; Royal United Hospital, Bath, UK., Wilson C; Addenbrookes Hospital, Cambridge, UK., Ellis R; Royal Cornwall Hospital NHS Trust, Truro, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Dhadda AS; Castle Hill Hospital, Hull, UK., Harrison M; Mount Vernon Cancer Centre, Northwood, UK., Falk S; Bristol Cancer Institute, Bristol, UK., Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Bridgewater J; UCL Cancer Institute, University College London, London UK., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK., Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK., Cunningham D; Royal Marsden Hospital, London, UK., Hickish T; Poole Hospital, Bournemouth University, Bournemouth, UK., Weaver A; Department of Oncology, Oxford University Hospitals Foundation Trust, Oxford, UK., Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK., Wasan HS; Hammersmith Hospital, Imperial College London, London, UK., Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Apr; Vol. 19 (4), pp. 562-578.